← Human Trials & Peer-Reviewed Studies

Applicability of intraoperative parathyroid hormone assay during total thyroidectomy as a guide for the surgeon to selective parathyroid tissue autotransplantation

Plain-language guide to PMID 18246390 (2008): randomized controlled trial study of Parathyroid Hormone (PTH 1-84) in 2005, patients.

Key Facts

PMID
18246390
Journal
World journal of surgery
Year
2008
Study type
Randomized Controlled Trial
Authors
Barczyński M et al. (4 authors)
DOI
10.1007/s00268-007-9405-8

What This Study Did, in Plain Language

What Was Tested

Researchers studied Parathyroid Hormone (PTH 1-84) in this randomized controlled trial publication.

The objective of this study was to evaluate the applicability of IOPTH in guiding the surgeon to selective parathyroid tissue autotransplantation during total thyroidectomy (TT).

Why It Was Studied

However, the value of IOPTH has not been assessed in a randomized study as a guide for the surgeon to parathyroid tissue autotransplantation (PA).

Who Took Part

According to the abstract, 2005, patients were involved.

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

Between January 2005 and December 2005, 340 patients qualified for total thyroidectomy (TT) who met the inclusion criteria were randomized to two equal-sized groups (n=170): group A, in which elective PA of at least one parathyroid gland was performed in all cases without IOPTH as a guide; and group B, in which selective IOPTH-guided PA was performed, if only the iPTH plasma level was <10 ng/L at 10-20 min after TT (before skin closure).

IOPTH measurements were performed by the STAT-Intraoperative-iPTH-Assay.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Parathyroid Hormone (PTH 1-84) and who got the comparison, which limits bias.

The standard technique of PA consisting of implanting the parathyroid tissue into 10-20 sternocleidomastoid muscle pockets was used in both groups.

Serum calcium was routinely monitored at 4, 12, 24, 48, and 72 hr postoperatively.

The incidence and severity of hypocalcemia and related symptoms were matched with the IOPTH results.

On follow-up, serum calcium and plasma iPTH values were measured at 1, 3, and 6 months postoperatively.

The secondary end point was the use of postoperative medication for transient hypocalcemic symptoms.

What Was Measured

However, the value of IOPTH has not been assessed in a randomized study as a guide for the surgeon to parathyroid tissue autotransplantation (PA).

PubMed files the paper under topics including Hypoparathyroidism, Monitoring, Intraoperative, Parathyroid Glands, Parathyroid Hormone, Patient Selection, Thyroid Diseases and Thyroidectomy.

What This Means in Plain Language

The paper is a randomized study of Parathyroid Hormone (PTH 1-84) in 2005, patients.

With several hundred people or more, it is a fairly large study for this kind of research.

Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2008 (World journal of surgery), a journal based in United States.

More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.

Our Notes on the Compound

Parathyroid Hormone (PTH 1-84): The 84-amino-acid hormone that raises blood calcium; full-length PTH (Natpara) has been used in hypoparathyroidism. Teriparatide is its 1-34 fragment.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.